Measles in the United States is on the rise, triggering quarantine actions in some South Carolina schools and prompting urgent discussions about vaccination and preparedness amid falling immunity rates. The nationwide tally is approaching two thousand confirmed cases—the highest in more than twenty years. A recent outbreak in a public school in South Carolina led to quarantines after exposure, fueling concerns that sustained transmission could jeopardize the nation’s measles-elimination goals.
With vaccination rates slipping and outbreaks continuing, people are asking how best to respond and whether the U.S. is adequately ready to handle ongoing, potentially escalating outbreaks.
How many US measles cases are there?
As of December 10, 2025, the CDC reports 1,912 measles cases nationwide, with concentrations in several states: Texas (805), South Carolina (129), New Mexico (100), Arizona (169), and Utah (115). The majority involve unvaccinated individuals or people with unknown vaccination histories, and most patients are aged 5–19.
The SC outbreak has intensified the public conversation about measles. Reports indicate roughly 250 people were exposed, and most confirmed cases are centered in Spartanburg County. In response, the school instituted quarantine measures and shifted students to remote learning temporarily.
Governor Henry McMaster framed the debate in terms of personal choice on vaccination, saying, “There are some people who don’t want to do it, and that’s up to them. People need to understand it’s dangerous just like many other diseases. If there’s any way to prevent it, you ought to do it.”
The reappearance of quarantines and distance learning evokes COVID-era memories and raises broader questions about how communities, policymakers, and health systems will handle ongoing—and possibly worsening—measles outbreaks. Addressing misinformation, improving health literacy, and supporting vaccination efforts are more critical than ever.
What is measles—and how bad can it be?
Measles is one of the most contagious communicable diseases, typically presenting with high fever and a distinctive red, blotchy rash that spreads across the body. Most individuals recover within about 10 days, but the illness can be severe and even deadly for young children under five or for people with weakened immune systems. In addition to immediate complications, measles can lead to a rare but serious long-term condition called subacute sclerosing panencephalitis (SSPE), a progressive neurodegenerative disease. A recent case in Los Angeles highlighted this grave risk. SSPE occurs in roughly 1 in 10,000 people infected with measles, rising to about 1 in 600 when infection occurs in infancy. It typically manifests years after the initial illness and currently has no cure, with patients often surviving only 2–3 years after diagnosis.
These serious outcomes underscore why vaccination is essential—not only to protect individuals but also to reduce transmission to vulnerable populations who cannot receive vaccines.
Is the MMR vaccine safe?
The measles, mumps, and rubella (MMR) vaccine is well-studied, safe, and highly effective at preventing measles and its complications. Two doses confer about 97% protection. Widespread use has substantially reduced measles-related illness and death worldwide. Serious adverse events after MMR are rare, and extensive research has found no link between the vaccine and autism or other chronic conditions. Because MMR is a live attenuated vaccine, it is not recommended for certain groups, such as severely immunocompromised individuals or pregnant people, making high community vaccination coverage especially important.
For herd immunity—or community protection—we typically target about 95% vaccination coverage. While not everyone can be vaccinated, achieving roughly 95% coverage helps safeguard the greatest number of people, according to expert insights.
How can pharmacists support communities during outbreaks?
Pharmacists are pivotal in outbreak response and prevention. Key roles include:
- educating patients about how measles spreads, its symptoms, potential complications, and the value of vaccination;
- countering misinformation with evidence-based guidance on vaccine safety and effectiveness;
- facilitating access to vaccines and identifying individuals who are overdue for immunization;
- staying informed about local and national outbreak trends to provide timely guidance and referrals; and
- reinforcing infection control measures, including isolation guidance and clear instructions on when to seek care.
As trusted, accessible health professionals, pharmacists are uniquely positioned to strengthen community preparedness and mitigate the impact of vaccine-preventable outbreaks.
References and further reading are kept in the original sources listed in the materials, including public health updates, CDC data, and coverage of the SC outbreak and policy responses.
Would you like this rewritten content tailored for a specific audience (for example, patients, healthcare professionals, or policy makers) or adjusted to fit a particular word count or publication style?
